Imidazo[4,5-d]thiazolo[5,4-b]pyridine based inhibitors of IKK2: Synthesis, SAR, PK/PD and activity in a preclinical model of rheumatoid arthritis

  • Alaric J. Dyckman
  • , Charles M. Langevine
  • , Claude Quesnelle
  • , James Kempson
  • , Junqing Guo
  • , Patrice Gill
  • , Steven H. Spergel
  • , Scott H. Watterson
  • , Tianle Li
  • , David S. Nirschl
  • , Kathleen M. Gillooly
  • , Mark A. Pattoli
  • , Kim W. McIntyre
  • , Laishun Chen
  • , Murray McKinnon
  • , John H. Dodd
  • , Joel C. Barrish
  • , James R. Burke
  • , William J. Pitts

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

The synthesis, structure-activity relationships (SAR) and biological evaluation of thiazole based tricyclic inhibitors of IKK2 are described. Compound 9 was determined to be orally efficacious in a murine model of rheumatoid arthritis.

Original languageEnglish (US)
Pages (from-to)383-386
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume21
Issue number1
DOIs
StatePublished - Jan 1 2011

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Imidazo[4,5-d]thiazolo[5,4-b]pyridine based inhibitors of IKK2: Synthesis, SAR, PK/PD and activity in a preclinical model of rheumatoid arthritis'. Together they form a unique fingerprint.

Cite this